This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Christian-Albrechts-Universitaet Zu Kiel. Active years: 2011.
Company Filing History:
Years Active: 2011
Title: Uwe Buss: Innovator in NO-synthase Inhibition
Introduction
Uwe Buss is a notable inventor based in Kiel, Germany. He has made significant contributions to the field of biochemistry, particularly in the development of inhibitors for nitric oxide synthases. His work has implications for various medical applications, showcasing the importance of innovation in scientific research.
Latest Patents
Uwe Buss holds a patent titled "Basic acetophenones as inhibitors of NO-synthases." This patent describes the use of a substance characterized by a general structural formula for the preparation of an agent that inhibits the enzymatic activity of NO-synthase. The structural components include R1, R2, R3, R4, and/or R5, which can be hydrogen, an alkyl group, an aryl group, or a heterocyclic group, with n equaling 2 or 3. This innovation represents a significant advancement in the understanding and manipulation of biochemical pathways.
Career Highlights
Throughout his career, Uwe Buss has been associated with prestigious institutions, including Christian-Albrechts-Universität zu Kiel. His work at this university has allowed him to engage in cutting-edge research and contribute to the academic community. His dedication to advancing scientific knowledge is evident in his patent and ongoing research efforts.
Collaborations
Uwe Buss has collaborated with notable colleagues such as Ullvi Bluhm and Bernd Clement. These partnerships have likely enriched his research and contributed to the successful development of his innovative ideas.
Conclusion
Uwe Buss is a distinguished inventor whose work in NO-synthase inhibition has the potential to impact medical science significantly. His patent and collaborations reflect his commitment to advancing biochemistry and innovation.